EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Determinants of C16-Ceramide Binding to p53

Madeline S Childress iD, Kristen A Jeffries, Sergey A Krupenko iD, Natalia I Krupenko iD

Biomolecules · 2026

DOI: 10.3390/biom16091343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Madeline S Childress und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Research Institute, UNC-Chapel Hill, Kannapolis, NC 28081, USA. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Ceramides. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, UNC Nutrition Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor suppressor p53 coordinates cellular stress responses, but underlying mechanisms remain incompletely understood. We previously demonstrated that, in response to metabolic stress, C16-ceramide produced by ceramide synthase 6 (CerS6) directly binds to p53, thus preventing its MDM2-mediated degradation and promoting p53 activation. Here, we investigated the structural requirements and functional consequences of ceramide binding to p53. Using a panel of p53 mutants, including naturally occurring oncogenic variants, we characterized the ceramide-binding interface of p53 and the role of amino acid substitutions within this region in metabolic stress signaling. We found that disruption of ceramide binding impaired stress-induced p53–CerS6 interaction at the endoplasmic reticulum (ER), attenuated induction of p53 target genes, and reduced cellular sensitivity to stress. Of note, certain cancer-associated p53 mutants retained ceramide binding and the ability to activate stress responses. These studies were further extended to monitoring the p53–CerS6 interaction on the ER and associated membrane aggregation using fluorescence techniques. We showed that metabolic stress-induced ER remodeling was distinct from the canonical UPR. Overall, our study defines the ceramide-binding surface within the p53 DNA-binding domain and provides novel insight into the functional role of the ceramide–p53 interaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53CeramidesHumansProtein BindingEndoplasmic ReticulumSphingosine N-AcyltransferaseMutationBinding SitesOxidoreductases

Stichwörter der Autor:innen

C16-ceramideCerS6ER stressmutant p53p53 activationsphingolipid signaling

Substanzen

Tumor Suppressor Protein p53CeramidesN-palmitoylsphingosineSphingosine N-Acyltransferasedihydroceramide desaturaseTP53 protein, humanOxidoreductases

Autor:innen und Institutionen

  • Nutrition Research Institute, UNC-Chapel Hill, Kannapolis, NC 28081, USA.
  • Department of Nutrition, UNC-Chapel Hill, Chapel Hill, NC 27599, USA.

ORCID-Profile: Madeline S Childress, Sergey A Krupenko, Natalia I Krupenko

Förderung

  • NCI NIH HHS
  • NIH HHS
  • UNC Nutrition Research Institute
  • NIH
  • UNC NRI

Zitieren

APA

Childress, M. S., Jeffries, K. A., Krupenko, S. A., & Krupenko, N. I. (2026). Determinants of C16-Ceramide Binding to p53. Biomolecules. https://doi.org/10.3390/biom16091343

Vancouver

Childress MS, Jeffries KA, Krupenko SA, Krupenko NI. Determinants of C16-Ceramide Binding to p53. Biomolecules. 2026. doi:10.3390/biom16091343

BibTeX
@article{Childress2026,
  author = {Childress, Madeline S and Jeffries, Kristen A and Krupenko, Sergey A and Krupenko, Natalia I},
  title = {Determinants of C16-Ceramide Binding to p53},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091343}
}
Kostenlos starten →